Policy & Regulation
21 August 2019 - Biotechnology company NKMax America stated on Tuesday that it has dosed its first patient with plaque psoriasis under its SNK01-MX03 phase I clinical trial of SNK at Angeles Hospital,...
21 August 2019 - AstraZeneca Plc (LON:AZN), a global, science-led biopharmaceutical company, reported on Tuesday positive results from the landmark phase III DAPA-HF trial, which showed that Farxiga (...
21 August 2019 - Pharmaceutical company Cassiopea SpA (SIX:SKIN) said on Tuesday that it has filed a New Drug Application (NDA) with the US Food and Drug Administration (FDA) seeking marketing approva...
21 August 2019 - Provention Bio Inc (Nasdaq: PRVB), a clinical stage biopharmaceutical company involved in intercepting and preventing immune-mediated diseases, announced yesterday that it has named S...
21 August 2019 - The United States Food and Drug Administration (FDA) has granted fast track designation to United States-based Moderna for its investigational Zika vaccine, mRNA-1893, it was reported...
21 August 2019 - Knopp Biosciences LLC, a drug discovery and development company, announced yesterday that it has commenced phase two dose-ranging clinical trial of oral dexpramipexole in moderate-to-...